Regulus Therapeutics Inc (RGLS)
2.20
+0.07
(+3.29%)
USD |
NASDAQ |
Apr 22, 16:00
2.11
-0.09
(-4.09%)
Pre-Market: 09:26
Regulus Therapeutics Cash and Short Term Investments (Quarterly): 23.77M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 23.77M |
| September 30, 2023 | 30.78M |
| June 30, 2023 | 37.26M |
| March 31, 2023 | 30.31M |
| December 31, 2022 | 39.16M |
| September 30, 2022 | 45.32M |
| June 30, 2022 | 47.53M |
| March 31, 2022 | 53.90M |
| December 31, 2021 | 60.38M |
| September 30, 2021 | 35.85M |
| June 30, 2021 | 41.44M |
| March 31, 2021 | 31.60M |
| December 31, 2020 | 31.09M |
| September 30, 2020 | 17.84M |
| June 30, 2020 | 23.42M |
| March 31, 2020 | 28.05M |
| December 31, 2019 | 34.12M |
| September 30, 2019 | 14.65M |
| June 30, 2019 | 19.57M |
| March 31, 2019 | 10.32M |
| December 31, 2018 | 13.94M |
| September 30, 2018 | 20.52M |
| June 30, 2018 | 32.86M |
| March 31, 2018 | 45.13M |
| Date | Value |
|---|---|
| December 31, 2017 | 60.07M |
| September 30, 2017 | 71.37M |
| June 30, 2017 | 40.09M |
| March 31, 2017 | 57.46M |
| December 31, 2016 | 76.11M |
| September 30, 2016 | 91.58M |
| June 30, 2016 | 107.54M |
| March 31, 2016 | 105.10M |
| December 31, 2015 | 114.06M |
| September 30, 2015 | 130.33M |
| June 30, 2015 | 139.37M |
| March 31, 2015 | 148.79M |
| December 31, 2014 | 159.74M |
| September 30, 2014 | 94.06M |
| June 30, 2014 | 103.50M |
| March 31, 2014 | 114.60M |
| December 31, 2013 | 114.00M |
| September 30, 2013 | 123.90M |
| June 30, 2013 | 82.72M |
| March 31, 2013 | 90.72M |
| December 31, 2012 | 98.10M |
| September 30, 2012 | 30.89M |
| June 30, 2012 | 27.01M |
| December 31, 2011 | 38.14M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
14.65M
Minimum
Sep 2019
60.38M
Maximum
Dec 2021
34.00M
Average
31.60M
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 438.86M |
| ADMA Biologics Inc | 51.35M |
| FibroGen Inc | 235.59M |
| Protara Therapeutics Inc | 65.58M |
| Amylyx Pharmaceuticals Inc | 371.36M |